Allergan To Pay $958 Million For MAP
MAP Pharmaceuticals Inc. (Nasdaq: MAPP) will be acquired by Allergan INc. (NYSE: AGN) for a premium of approximately $958 million in cash. Shares of MAP leaped $9.12 to $24.70 while Allergan stock lost $1.13 to $104.62.

Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here